Health Archive » July, 2006

Health - July, 2006

143 articles

• FDA Breast Implant Decisions Cleared By Senate Panel
• In Reversal, FDA Opens Door To Morning-After Pill
• State Attorneys General Reject Revised Plavix Deal
• Digene Wins Arbitration Ruling Over HPV License
• ImClone Motion Denied In Erbitux Case
• Boston Scientific, St. Jude Settle Four Patent Suits
• Smith & Nephew Blames Sales Rep In Antitrust Probe
• FTC Probes Mylan Over Provigil Settlements
• Pfizer Puts General Counsel In Charge
• House Passes Medical Data Technology Bill
• FBI Raids Bristol-Myers Over Plavix Deal
• Trial Begins In Latest Wyeth Diet Drug Case
• Intermune Eyes Settlement Over Off-Label Marketing
• Biomet Says DoJ Scales Down Antitrust Probe
• Shareholders Take Aim At HCA Buyout Deal
• SEC Settles Case Over Insider Trading On FDA Decision
• J&J Unit Takes On Wyeth's Effexor In Patent Suit
• Zimmer Tries To Clear Name In Price-Fixing Scandal
• Bill Would Move Vaccine Safety Out Of CDC
• Abbott Wins Antitrust Challenge Over HIV Drug Cocktail
• DOJ Launches Criminal Probe Into Plavix Deal
• HealthSouth Gets New General Counsel
• Universities, Hospitals Join Patent Litigation Bonanza
• Tyco Sticks Applied Medical With Fresh Patent Suit
• Korea Pushes Drug-Pricing Law
• Judge Tosses Patent Case Against Stryker
• Invitrogen Gets Biotech Patent Win In Jury Trial
• Jury Awards $5M In Infant Tylenol Poisoning Case
• Judge Holds Off On Hospital Settlement Approval
• Eye Care Company Says It's Not Eyeing Rival's Patent
• Upsher-Smith, Unigene Sue Apotex After ANDA Filing
• St. Vincent Sells Off Hospital In $15M Deal
• SEC Investigates Par Pharmaceutical
• Orthopedic Industry Braces For Possible Storm
• Lawsuits, Investigations Unaffected By HCA Sale
• States Wade Into Stem-Cell Research Controversy
• Union Ordered To Pay Fine For Defamation
• America's Top Health Litigators: Drinker Biddle & Reath
• N.J. High Court Mulls Vioxx Class Status; $30B At Stake
• RxUSA Files New Suit Against Wholeseller
• Plavix Ruling From Attorneys General Imminent
• FDA Bolsters Rules On Outside Advisors
• Shareholders Committee Will Stay In OCA Bankruptcy
• Another Exec Fined In HealthSouth Scandal
• Swiss University Sues Synthes In Pilot Case
• Early Approval For Astra's Asthma Drug Stuns Analysts
• Amgen Criticizes Roche's Anemia Study
• Erbitux Trial Awaits Judge's Decision
• Par Pharmaceutical Hit With Securities Suits
• Senators Take Aim At Authorized Generics
• Judge: No Infringement In Assays Patent Case
• Roche Rallies In Wake Of Enzo Biochem Ruling
• Orthopedic Company Antitrust Subpoena "Narrowed"
• Political Pressure-Cooker Mentality At FDA: Report
• America's Top Health Litigators: Reed Smith
• Hospital To Pay $3.75M Over Kickback Scheme
• Judge OKs St. Vincent's $21.2M Hospital Sell-Off
• Elan Files Patent Suit Over Breast Cancer Drug
• America's Top Health Litigators: McDermott Will & Emery
• Endocare Settles Fraud Case With SEC, DOJ
• Suit Alleges Conspiracy Among Drug Cos., Wholesalers
• FTC Commissioner Slams Authorized Generics
• ImClone, Merck Reach Deal Over Erbitux
• Hospital Settlement Attracts Scrutiny
• Fed. Circuit Affirms University's Grip On Allergy Patent
• Court Issues Markman Ruling In Enzo Biochem Case
• E-mails Question FDA Review Process For Ketek
• Bush Vetoes Stem-Cell Funding On "Moral" Grounds
• Encore Medical Shareholders Target $870M Merger
• Fourth Circuit Rejects Another Authorized Generics Challenge
• "Wal-Mart Law" Struck Down In Federal Court
• Group Looks To Overturn Stem Cell Patents
• America's Top Health Litigators: Sidley Austin
• Court Finds Non-Infringement In Alaris, ICU Case
• Beazley Scores U.S. Health Care Legal Veteran
• Settlement Gets To Heart Of Stent Lawsuit
• U.S. Trustee Objects To World Health Asset Sale
• FDA OKs Medtronic's New Glucose Monitor
• Jury Denies Baxter's $87M Bid In Dialysis Dispute
• Bio-Rad Settles Lengthy Licensing Dispute
• Medtronic To Pay $40M To Settle Kickback Charges
• Senate Clears Stem-Cell Funding As Veto Looms
• Court Upholds Blood Pressure Drug Patent
• Six Years After Wyeth Debacle, Birth Control Rod OK'd
• America's Top Health Litigators: Jones Day
• Shadow Of Veto Clouds Senate Stem-Cell Vote
• Eli Lilly Gets Green Light For New Use Of Gemzar
• Generic Drug Maker Gets Chapter 11 OK
• America's Top Health Litigators: Fitzpatrick, Cella
• Orthopedic Makers Conspired To Fix Prices, Suit Claims
• Pfizer Stuck With 17 New Lipitor Suits
• FDA Opts To Fast Track Constipation Drug
• Roche, Sanofi Settle Australian Vitamins Cartel Action
• In Blow To Ivax, Judge Upholds Lexapro Patent
• Rulings Highlight Community Patent Rift
• Class Action Adds To Drug Maker's Troubles
• Five Suits Charge Blue Shield Abandoned Patients
• FDA Calls Off Closed Hearing On Blood Substitute
• America's Top Health Litigators: McCarter & English
• Lawmakers Try To Put Brakes On Medicare Overhaul
• New Study Supports Biotech Fears Over USPTO Changes
• FDA Draws Fire For Closed Hearing On Blood Substitute
• America's Top Health Litigators: Kaye Scholer
• Health Courts? No Thanks, Say Trial Lawyers
• Merck Wins New Jersey Vioxx Case
• Generic Drug Settlement Prompts More FTC Scrutiny
• Merck Strategy Still Murky As Jury Mulls Vioxx Claims
• Senate Votes To Allow Access To Canadian Drugs
• America's Top Health Litigators: Shook, Hardy & Bacon
• Judge Tosses Sandoz' Injunctive Bid Over Zocor
• FDA Backs Boston Scientific's Recall Of Heart Devices
• Hospice Co. Pays $13M To Settle False Claims Probes
• SeraCare, Shareholders Agree To Exclusivity Deal
• HealthSouth Bigwig Loses Appeal In Fraud Case
• Dusa Targets Chemical Supplier, Physicians In Suits
• Under Vioxx Fire, Merck Faces Fosamax Claims Too
• Lawyer: Heart Attack Caused By Bad Health, Not Vioxx
• America's Top Health Litigators: Dechert
• Forest Sues To Keep Generic Lexapro Off Market
• FDA Slacking On Post-Approval Follow-Up: Report
• FTC Scrutiny Casts Doubt On Plavix Settlement
• Medegen Unit Hits ICU Medical With Suit
• CalPERS Sues UnitedHealth Over Options Backdating
• Future Looks Grim For Charitable Hospitals
• Vision Companies Settle Patent Dispute
• Chemical Cos. Settle Spat Over Cystic Fibrosis Drug
• Amgen Loses Battle In Anemia War With La Roche
• Lawsuit Targets Director Of USPTO
• Government Softens Blow Of Medicaid Identity Law
• Lord Bissell's Health Care Practice Balloons
• As Drug Risks Mount, Senators Put Pressure On FDA
• 10 Stand-Out Firms Win Industry's Confidence
• Defendants Cave To Acacia Over Resource Tools
• Tenet Settles One Year After Katrina
• Shareholders Seek To End SeraCare's Ch. 11 Control
• J&J Subsidiaries Fight Back Generic Challenge
• FTC Detects Cancer Screening Monopoly
• University, Nektar Settle Patent Feud For $25M
• Doctor Testifies Merck Knew Of Vioxx Risk
• Hospitals Rail Against Medicaid Citizenship Law
• Device Makers Settle Suit Over Incontinence Treatment
• Ruling Sets Up Patent Battle Over Growth Treatment
• Citizen Petitions Come Under Fire In Pharma War